Page last updated: 2024-09-05

sorafenib and genkwanin

sorafenib has been researched along with genkwanin in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(genkwanin)
Trials
(genkwanin)
Recent Studies (post-2010) (genkwanin)
6,5207305,25171039

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)genkwanin (IC50)
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)1.7
MAP kinase-interacting serine/threonine-protein kinase 2Homo sapiens (human)0.979

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, LC; Hsu, KC; Huang, HL; Huang, WJ; Lien, ST; Lin, TE; Ngo, ST; Pan, SL; Sung, TY; Tseng, HJ; Wu, YW; Yen, SC1

Other Studies

1 other study(ies) available for sorafenib and genkwanin

ArticleYear
Investigation of Selected Flavonoid Derivatives as Potent FLT3 Inhibitors for the Potential Treatment of Acute Myeloid Leukemia.
    Journal of natural products, 2021, 01-22, Volume: 84, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Flavonoids; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mutation; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays

2021